Lion TCR
Lion TCR is a biotechnology company developing cell tehrapies for the treatment of viral infections and viral-related cancers.
1
Funding Rounds
$20.0m
Money raised
Funding series
Funding Series Analysis
The company Lion TCR has raised a total of $20m in funding over 1 rounds.
Key Insights:
- Lion TCR Series A round, May 2018: $20m
Lion TCR Series A round, May 2018
$20m
Industries
Lion TCR is active in the following industries:
- Regenerative medicine
- Healthcare
- Cell therapy
- Biomedical engineering
- Biopharmaceutical
- Technology
- Biology
- Biotechnology
- Immunotherapy
- Engineering